Reward Devaluation: Dot-Probe Meta-Analytic Evidence of Avoidance of Positive Information in Depressed Persons

Por Winer, E. Samuel, Salem, Taban
Publicado no Psychol Bull (2015)

Combined Behavioral Markers of Cognitive Biases are Associated with Anhedonia

Por Salem, Taban, Winer, E. Samuel, Nadorff, Michael R.
Publicado no Cogn Emot (2017)

Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?

Por Vaz-Luis, I., Winer, E. P., Lin, N. U.
Publicado em 2013

Struggling toward reward: Recent experience of anhedonia interacts with motivation to predict reward pursuit in the face of a stressful manipulation

Por Bryant, Jessica, Winer, E. Samuel, Salem, Taban, Nadorff, Michael R.
Publicado no PLoS One (2017)

Longitudinal Evaluation of Anhedonia as a Mediator of Fear of Positive Evaluation and Other Depressive Symptoms

Por Jordan, D. Gage, Winer, E. Samuel, Salem, Taban, Kilgore, Jenna
Publicado no Cogn Emot (2017)

Unpacking Sleep and Suicide in Older Adults in a Combined Online Sample

Por Golding, Shea, Nadorff, Michael R., Winer, E. Samuel, Ward, Kathryn Claire
Publicado no J Clin Sleep Med (2015)

A Short-Term Longitudinal Examination of the Relations between Depression, Anhedonia, and Self-Injurious Thoughts and Behaviors in Adults with a History of Self-Injury

Por Zielinski, Melissa J., Veilleux, Jennifer C., Winer, E. Samuel, Nadorff, Michael R.
Publicado no Compr Psychiatry (2016)

Mapping the Relationship between Anxiety, Anhedonia, and Depression

Por Winer, E. Samuel, Bryant, Jessica, Bartoszek, Gregory, Rojas, Enrique, Nadorff, Michael R., Kilgore, Jenna
Publicado no J Affect Disord (2017)

Overestimation of hereditary breast cancer risk.

Por Iglehart, J D, Miron, A, Rimer, B K, Winer, E P, Berry, D, Shildkraut, M J
Publicado em 1998

Explaining Alcohol Use and Suicide Risk: A Moderated Mediation Model Involving Insomnia Symptoms and Gender

Por Nadorff, Michael R., Salem, Taban, Winer, E. Samuel, Lamis, Dorian A., Nazem, Sarra, Berman, Mitchell E.
Publicado no J Clin Sleep Med (2014)

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer

Por Mayer, E. L., Partridge, A. H., Harris, L. N., Gelman, R. S., Schumer, S. T., Burstein, H. J., Winer, E. P.
Publicado no Breast Cancer Res Treat (2009)

Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840

Por Lichtman, S. M., Hurria, A., Cirrincione, C. T., Seidman, A. D., Winer, E., Hudis, C., Cohen, H. J., Muss, H. B.
Publicado em 2012

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Por Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J.
Publicado no Ann Oncol (2015)

Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer

Por Olson, E. M., Lin, N. U., DiPiro, P. J., Najita, J. S., Krop, I. E., Winer, E. P., Burstein, H. J.
Publicado em 2012

A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer

Por Tolaney, S. M., Najita, J., Sperinde, J., Huang, W., Chen, W. Y., Savoie, J., Fornier, M., Winer, E. P., Bunnell, C., Krop, I. E.
Publicado em 2013

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)

Por Ruddy, K. J., Pitcher, B. N., Archer, L. E., Cohen, H. J., Winer, E. P., Hudis, C. A., Muss, H. B., Partridge, A. H.
Publicado em 2012

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by...

Por Kimmick, G. G., Cirrincione, C., Duggan, D. B., Bhalla, K., Robert, N., Berry, D., Norton, L., Lemke, S., Henderson, I. C., Hudis, C., Winer, E.
Publicado em 2008

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809

Por Shapiro, C. L., Halabi, S., Hars, V., Archer, L., Weckstein, D., Kirshner, J., Sikov, W., Winer, E., Burstein, H.J., Hudis, C., Isaacs, C., Schilsky, R., Paskett, E.
Publicado em 2011

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia

Por Reagan, J L, Fast, L D, Nevola, M, Mantripragada, K, Mulder, A, Claas, F H J, Rosati, K, Schumacher, A, Safran, H, Young, C T, Quesenberry, M I, Winer, E S, Butera, J N, Quesenberry, P J
Publicado no Blood Cancer J (2015)

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy

Por Abramson, J. S., Feldman, T., Kroll-Desrosiers, A. R., Muffly, L. S., Winer, E., Flowers, C. R., Lansigan, F., Nabhan, C., Nastoupil, L. J., Nath, R., Goy, A., Castillo, J. J., Jagadeesh, D., Woda, B., Rosen, S. T., Smith, S. M., Evens, A. M.
Publicado no Ann Oncol (2014)